FDA UNTITLED_LETTER - Molecular PharmaGroup - July 28, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Molecular PharmaGroup

Record Details

This UNTITLED LETTER record concerns Molecular PharmaGroup, with an inspection on July 28, 2025, issued by the Office of Pharmaceutical Quality.

Company: Molecular PharmaGroup
Inspection Date: July 28, 2025
Office: Office of Pharmaceutical Quality
Person: Matthew J. Lash (Acting Director)

Open in Dashboard

ID · eacf3ea6-9ce4-4efd-98e1-ab502c36fa49

Violation Codes10

21 U.S.C. 331(c)21 U.S.C. § 352(f)(1)21 U.S.C. § 321(p)21 U.S.C. 360eee-121 U.S.C. 351(a)(2)(A)21 U.S.C. 33121 U.S.C. 353b21 U.S.C. 351(a)(2)(B)21 U.S.C. §§ 331(d)21 U.S.C. 355(a)

Full citation text and observation details available on the Dashboard.